BNP Paribas Financial Markets’s Reata Pharmaceuticals, Inc. Class A Common Stock RETA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2023
Q3
Sell
-56,365
Closed -$5.75M 3340
2023
Q2
$5.75M Buy
56,365
+22,601
+67% +$2.3M 0.01% 827
2023
Q1
$3.07M Buy
33,764
+4,481
+15% +$407K ﹤0.01% 1130
2022
Q4
$1.11M Sell
29,283
-32,367
-53% -$1.23M ﹤0.01% 1524
2022
Q3
$1.55M Sell
61,650
-20,322
-25% -$511K ﹤0.01% 1588
2022
Q2
$2.49M Buy
81,972
+24,938
+44% +$758K ﹤0.01% 1165
2022
Q1
$1.87M Buy
57,034
+22,592
+66% +$740K ﹤0.01% 1420
2021
Q4
$908K Buy
34,442
+12,483
+57% +$329K ﹤0.01% 2080
2021
Q3
$2.21M Buy
21,959
+15,989
+268% +$1.61M ﹤0.01% 1366
2021
Q2
$845K Buy
5,970
+4,841
+429% +$685K ﹤0.01% 1756
2021
Q1
$113K Buy
1,129
+328
+41% +$32.7K ﹤0.01% 2745
2020
Q4
$99K Buy
801
+321
+67% +$39.7K ﹤0.01% 2568
2020
Q3
$46.8K Sell
480
-6,393
-93% -$623K ﹤0.01% 2872
2020
Q2
$1.07M Sell
6,873
-639
-9% -$99.7K ﹤0.01% 1280
2020
Q1
$1.08M Buy
7,512
+4,340
+137% +$626K ﹤0.01% 1380
2019
Q4
$648K Sell
3,172
-510
-14% -$104K ﹤0.01% 1694
2019
Q3
$296K Buy
3,682
+1,121
+44% +$90K ﹤0.01% 1924
2019
Q2
$242K Sell
2,561
-1,824
-42% -$172K ﹤0.01% 1903
2019
Q1
$375K Buy
4,385
+4,207
+2,363% +$360K ﹤0.01% 1743
2018
Q4
$9.99K Sell
178
-589
-77% -$33K ﹤0.01% 2681
2018
Q3
$62.7K Buy
767
+184
+32% +$15K ﹤0.01% 2304
2018
Q2
$20.4K Sell
583
-1,873
-76% -$65.5K ﹤0.01% 2845
2018
Q1
$50.4K Buy
2,456
+44
+2% +$902 ﹤0.01% 2982
2017
Q4
$68.3K Buy
2,412
+1,559
+183% +$44.2K ﹤0.01% 2846
2017
Q3
$26.5K Sell
853
-72
-8% -$2.24K ﹤0.01% 2949
2017
Q2
$29.3K Buy
925
+840
+988% +$26.6K ﹤0.01% 2941
2017
Q1
$1.93K Sell
85
-190
-69% -$4.3K ﹤0.01% 2981
2016
Q4
$6K Sell
275
-120
-30% -$2.62K ﹤0.01% 3060
2016
Q3
$10.4K Buy
395
+170
+76% +$4.48K ﹤0.01% 3157
2016
Q2
$4.44K Buy
+225
New +$4.44K ﹤0.01% 3312